BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6159077)

  • 1. Sequential combination chemotherapy with vinblastine-bleomycin and doxorubicin-cis-dichlorodiammineplatinum(II) in disseminated nonseminomatous testicular cancer.
    Scheulen ME; Seeber S; Schilcher RB; Meier CR; Schmidt CG
    Cancer Treat Rep; 1980; 64(4-5):599-609. PubMed ID: 6159077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of non-seminomatous testicular tumors in combination with vinblastine/bleomycin and adriamycin/cisplatin].
    Boewer C; Fleck H; Uibel M; Nawka S
    Z Urol Nephrol; 1982 May; 75(5):315-23. PubMed ID: 6180571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of metastatic nonseminomatous testicular cancer: a preliminary report of induction chemotherapy followed by maintenance chemotherapy or radiotherapy.
    Sonntag RW; Senn HJ; Cavalli F
    Cancer Treat Rep; 1979; 63(9-10):1669-74. PubMed ID: 91436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential combination chemotherapy and surgery for disseminated testicular cancer: cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin remission-induction therapy followed by cyclophosphamide and adriamycin.
    Garnick MB; Canellos GP; Richie JP; Stark JJ
    Cancer Treat Rep; 1979; 63(9-10):1681-6. PubMed ID: 91438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy with cis-dichlorodiammineplatinum(II) in disseminated testicular cancer.
    Einhorn LH
    Cancer Treat Rep; 1979; 63(9-10):1659-62. PubMed ID: 91434
    [No Abstract]   [Full Text] [Related]  

  • 6. Vinblastine, bleomycin, and cis-dichlorodiammineplatinum(II) in disseminated testicular cancer: preliminary report of a Southwest Oncology Group Study.
    Samson MK; Stephens RL; Rivkin S; Opipari M; Maloney T; Groppe CW; Fisher R
    Cancer Treat Rep; 1979; 63(9-10):1663-7. PubMed ID: 91435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of disseminated seminoma.
    Einhorn LH; Williams SD
    Cancer Clin Trials; 1980; 3(4):307-13. PubMed ID: 6159120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for disseminated testicular cancer.
    Einhorn LH; Donohue JP
    Urol Clin North Am; 1977 Oct; 4(3):407-26. PubMed ID: 76358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sequential combination chemotherapy with vinblastine/bleomycin and adriamycin/cis-dichlorodiammineplatinum (II) in non-seminomatous testicular cancer. I. Results of a prospective randomized phase III-study with 71 patients with disseminated disease (stage IV) (author's transl)].
    Scheulen ME; Higi M; Schilcher RB; Meier CR; Seeber S; Schmidt CG
    Klin Wochenschr; 1980 Aug; 58(16):811-21. PubMed ID: 6161273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probable cure of metastatic testicular tumors treated with sequential therapy.
    Neidhart JA; Memo R; Metz EN; Wise H
    Cancer Treat Rep; 1980; 64(4-5):553-8. PubMed ID: 6159075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer.
    Bosl GJ; Kwong R; Lange PH; Fraley EE; Kennedy BJ
    Cancer Treat Rep; 1980; 64(2-3):331-4. PubMed ID: 6157467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for testicular cancer: current status of the National Cancer Institute Combined Modality Trial.
    Anderson T; Javadpour N; Schilsky R; Barlock A; Young RC
    Cancer Treat Rep; 1979; 63(9-10):1687-92. PubMed ID: 91439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture.
    Einhorn LH
    Cancer Res; 1981 Sep; 41(9 Pt 1):3275-80. PubMed ID: 6167346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for advanced germinal cell neoplasms: preliminary report of an Eastern Cooperative Oncology Group Study.
    DeWys WD; Begg C; Slayton R; Hahn RG; Brodsky I
    Cancer Treat Rep; 1979; 63(9-10):1675-80. PubMed ID: 91437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of maintenance therapy in disseminated testicular cancer.
    Einhorn LH; Williams SD; Troner M; Birch R; Greco FA
    N Engl J Med; 1981 Sep; 305(13):727-31. PubMed ID: 7022214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin.
    Krikorian JG; Daniels JR; Brown BW; Hu MS
    Cancer Treat Rep; 1978 Oct; 62(10):1455-63. PubMed ID: 81719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study of combination chemotherapy with cis-diamminedichloroplatinum for advanced genitourinary carcinoma].
    Nakatsu H; Nishimoto K; Moriyama H; Ehara S; Igawa M; Ishino T; Kodama M; Fujii M; Ukai R; Nihira H
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):702-9. PubMed ID: 6892199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preoperative chemotherapy of testicular cancer and Wilm's tumor].
    Kawai T
    Gan To Kagaku Ryoho; 1985 May; 12(5):1025-30. PubMed ID: 2581512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.